Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

AT1 antagonists in the treatment of CHF

Aug. 28, 2000

Insulin demonstrates antiatherosclerotic properties

Aug. 28, 2000

Soluble guanylyl cyclase activation by YC-1 reduces blood pressure in rats

Aug. 25, 2000

AGE formation inhibitor reduces hypertension and oxidative stress in SHRSP

Aug. 25, 2000

Vitamin E may prevent endothelial dysfunction

Aug. 25, 2000

ETA receptor blockade with LU-135252 assessed in preclinical studies

Aug. 25, 2000

CS-866 -- a novel angiotensin II antagonist in the news

Aug. 25, 2000

Seven key sessions and symposia from XXII ESC Congress available to Daily Essentials readers

Aug. 23, 2000

Efficacy of endothelin receptor antagonists in chronic heart failure compared

Aug. 23, 2000

Seven key sessions and symposia from XXII ESC Congress available to Daily Essentials readers

Aug. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...